美捷登 竭诚为您提供生物医学领域最新研究进展 :
 
  • 非酒精性脂肪肝会增加患心脏病的风险
    Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease N Engl J Med  (30 Sep 2010)
  • 体内体外实验证实抑制BMK1能够通过PML途径抑制肿瘤生长
    Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein Cancer Cell  PubMed (14 Sep 2010)
  • 爱的神奇力量,您知道吗?
    The Bigger Picture: Being loved Br Med J   (Sep 2010)
  • 胚胎干细胞治疗对于扩张型心肌病有良好疗效
    ATP-Sensitive K+ Channel-Deficient Dilated Cardiomyopathy Proteome Remodeled by Embryonic Stem Cell Therapy Stem Cells  PubMed (Aug 2010)
  • 一个IL-28B基因多态性决定HCV2型或3型患者接受利巴韦林治疗的效果
    An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response Gastroenterology  PubMed (Sep 2010)
  • 一项持续30年的关于大肠癌肺转移患者流行病学、治疗和预后的研究
    Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study Gut   PubMed (Sep 2010)
  • 经导管肺瓣膜置换术中短期疗效如何?
    Short- and Medium-Term Outcomes After Transcatheter Pulmonary Valve Placement in the Expanded Multicenter US Melody Valve Trial Circulation  PubMed (Sep 2010)
  • 心脏超声成像在冠状动脉疾病中的作用
    Cardiovascular magnetic resonance evaluation of the patient with known or suspected coronary artery disease Heart  PubMed (Sep 2010)
  • 中风过后的神经损伤是否由Toll样受体介导?
    Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol  PubMed (Aug 2010)
  • 渗透压释药的利他林治疗少儿多动症患者的双盲3期临床试验
    A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder J Clin Psychopharmacol  PubMed (Oct 2010)
  • IRF4是否在Th9细胞的发育中发挥作用?
    Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells Immunity  PubMed (29 July 2010)
  • 2009年泰缅边境地区难民中H1N1的流行情况
    Influenza in Refugees on the Thailand–Myanmar Border, May–October 2009 Emerg Infect Dis   PubMed (9 Sep 2010)
  • GPR120是Ω3脂肪酸受体,可能介导抗炎和胰岛素敏感效应
    GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects Cell   PubMed (3 Sep 2010)
  • 碳代谢在生物量和能量
    Central Carbon Metabolism as a Minimal Biochemical Walk between Precursors for Biomass and Energy Mol Cell   PubMed (10 Sep 2010)
  • 以血管生长因子为目标的抗癌治疗具有两面性
    Is there really a yin and yang to VEGF-targeted therapies? Lancet Oncol   PubMed (Sep 2010)
  • 血管紧张素转化酶抑制剂对稳定型冠状动脉疾病患者的治疗效果是由什么决定的?
    Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease Eur Heart J   PubMed (Sep 2010)
  • VEGF通过PLGA微粒缓释可以达到什么效果?
    Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia–reperfusion model J Control Release   PubMed (Oct 2010)
  • 对为贫困人群服务的医院究竟该不该进行经济鼓励?
    The Effect of Financial Incentives on Hospitals That Serve Poor Patients Ann Intern Med   PubMed (7 Sep 2010)
  • IDH1和IDH2突变在骨髓纤维化变性\血小板增多等患者中发挥什么样的作用?
    IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis Leukemia   PubMed (Sep 2010)
  • 长期应用抗炎药会不会增加房颤的风险?
    Long-term Use of Anti-inflammatory Drugs and Risk of Atrial Fibrillation Arch Intern Med   PubMed (Sep 2010)
近期美捷登生物医学最新研究进展 :
mailto:medjadenvip@gmail.com mailto:medjaden@gmail.com www.medjaden.com mailto:medjaden@126.com www.medjaden.com mailto:medjaden@gmail.com;medjaden@yahoo.com;